PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
40.36%
Some net income increase while MRVL is negative at -18.33%. John Neff would see a short-term edge over the struggling competitor.
1.10%
Some D&A expansion while MRVL is negative at -0.91%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
135.71%
Some yoy growth while MRVL is negative at -145.50%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
25.28%
SBC growth well above MRVL's 8.67%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-50.50%
Both reduce yoy usage, with MRVL at -405.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-275.27%
Both yoy AR lines negative, with MRVL at -22.72%. Martin Whitman would suspect an overall sector lean approach or softer demand.
47.06%
Some inventory rise while MRVL is negative at -145.27%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
163.41%
Lower AP growth vs. MRVL's 1401.12%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
159.46%
Some yoy usage while MRVL is negative at -490.94%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
250.00%
Well above MRVL's 15.95%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
30.00%
Some CFO growth while MRVL is negative at -55.89%. John Neff would note a short-term liquidity lead over the competitor.
11.72%
Some CapEx rise while MRVL is negative at -11.52%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-35.21%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
100.40%
Liquidation growth of 100.40% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
125.39%
Growth well above MRVL's 86.26%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
137.12%
We have mild expansions while MRVL is negative at -9.93%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.30%
Repurchase growth 1.25-1.5x MRVL's 66.16%. Bruce Berkowitz would confirm if the firm invests enough in expansions while boosting EPS.